H U Group Holdings (TSE:4544) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:4544 H U Group Holdings Inc TSE:4544
69 GF Score
Price 円3,244.00
GF Value 円2,771.74
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is H U Group Holdings Research & Development?

H U Group Holdings TSE:4544 +1.44% 69 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4544 with a GF Score™ of 69/100 and a GF Value™ of 円2,771.74 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. H U Group Holdings's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

H U Group Holdings  (TSE:4544) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

H U Group Holdings Research & Development Related Terms

H U Group Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for H U Group Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H U Group Holdings Research & Development Chart

H U Group Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

H U Group Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4544
69GF Score
H U Group Holdings Inc TSE:4544
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H U Group Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
H U Group Holdings (TSE:4544) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on H U Group Holdings and its competitors.
Is H U Group Holdings' Research & Development too high?
H U Group Holdings' current Research & Development is 円0 Mil. Overall, H U Group Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Research & Development compare to TMO and DHR?
H U Group Holdings' Research & Development of 円0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,771.74, compared to a current price of 円3,244.00 — trading 17% above its estimated fair value. The current Research & Development is 円0 Mil. H U Group Holdings' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H U Group Holdings (TSE:4544) Overvalued in 2026?

Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued. The current stock price of 円3,244.00 is trading 17% above its estimated GF Value™ of 円2,771.74. GuruFocus considers H U Group Holdings to be Modestly Overvalued.

Key valuation signals for TSE:4544:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,771.74 vs. price of 円3,244.00 (17% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H U Group Holdings Business Description

Other Exchanges MRCHF:USA
Address Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
69GF Score

Get the complete analysis for TSE:4544

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,244.00
Price
円2,771.74
GF Value